These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32598127)

  • 1. Vancomycin C-Terminus Guanidine Modifications and Further Insights into an Added Mechanism of Action Imparted by a Peripheral Structural Modification.
    Wu ZC; Cameron MD; Boger DL
    ACS Infect Dis; 2020 Aug; 6(8):2169-2180. PubMed ID: 32598127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maxamycins: Durable Antibiotics Derived by Rational Redesign of Vancomycin.
    Wu ZC; Boger DL
    Acc Chem Res; 2020 Nov; 53(11):2587-2599. PubMed ID: 33138354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral modifications of [Ψ[CH
    Okano A; Isley NA; Boger DL
    Proc Natl Acad Sci U S A; 2017 Jun; 114(26):E5052-E5061. PubMed ID: 28559345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total syntheses and initial evaluation of [Ψ[C(═S)NH]Tpg⁴]vancomycin, [Ψ[C(═NH)NH]Tpg⁴]vancomycin, [Ψ[CH₂NH]Tpg⁴]vancomycin, and their (4-chlorobiphenyl)methyl derivatives: synergistic binding pocket and peripheral modifications for the glycopeptide antibiotics.
    Okano A; Nakayama A; Wu K; Lindsey EA; Schammel AW; Feng Y; Collins KC; Boger DL
    J Am Chem Soc; 2015 Mar; 137(10):3693-704. PubMed ID: 25750995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C1-CBP-vancomycin: Impact of a Vancomycin C-Terminus Trimethylammonium Cation on Pharmacological Properties and Insights into Its Newly Introduced Mechanism of Action.
    Wu ZC; Isley NA; Okano A; Weiss WJ; Boger DL
    J Org Chem; 2020 Feb; 85(3):1365-1375. PubMed ID: 31670958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total synthesis of [Ψ[C(═NH)NH]Tpg(4)]vancomycin and its (4-chlorobiphenyl)methyl derivative: impact of peripheral modifications on vancomycin analogues redesigned for dual D-Ala-D-Ala and D-Ala-D-Lac binding.
    Okano A; Nakayama A; Schammel AW; Boger DL
    J Am Chem Soc; 2014 Oct; 136(39):13522-5. PubMed ID: 25211770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A redesigned vancomycin engineered for dual D-Ala-D-ala And D-Ala-D-Lac binding exhibits potent antimicrobial activity against vancomycin-resistant bacteria.
    Xie J; Pierce JG; James RC; Okano A; Boger DL
    J Am Chem Soc; 2011 Sep; 133(35):13946-9. PubMed ID: 21823662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Terminus Alkylation of Vancomycin: Ligand Binding Affinity, Antimicrobial Activity, and Site-Specific Nature of Quaternary Trimethylammonium Salt Modification.
    Wu ZC; Isley NA; Boger DL
    ACS Infect Dis; 2018 Oct; 4(10):1468-1474. PubMed ID: 30067012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate Inhibition of VanA by d-Alanine Reduces Vancomycin Resistance in a VanX-Dependent Manner.
    van der Aart LT; Lemmens N; van Wamel WJ; van Wezel GP
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4930-9. PubMed ID: 27270282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of the d-Ala-d-Lac-Terminated Peptidoglycan Structure in Vancomycin-Resistant Enterococcus faecalis Using a Combined Solid-State Nuclear Magnetic Resonance and Mass Spectrometry Analysis.
    Chang JD; Foster EE; Yang H; Kim SJ
    Biochemistry; 2017 Jan; 56(4):612-622. PubMed ID: 28040891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of an inducible vancomycin resistance system in Streptomyces coelicolor reveals a novel gene (vanK) required for drug resistance.
    Hong HJ; Hutchings MI; Neu JM; Wright GD; Paget MS; Buttner MJ
    Mol Microbiol; 2004 May; 52(4):1107-21. PubMed ID: 15130128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vancomycin-resistant Staphylococcus aureus].
    Rodríguez CA; Vesga O
    Biomedica; 2005 Dec; 25(4):575-87. PubMed ID: 16433184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-nucleotide polymorphisms in a vancomycin-resistant Staphylococcus aureus strain based on whole-genome sequencing.
    Kim JW; Lee KJ
    Arch Microbiol; 2020 Oct; 202(8):2255-2261. PubMed ID: 32535788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total synthesis of [Ψ[C(═S)NH]Tpg4]vancomycin aglycon, [Ψ[C(═NH)NH]Tpg4]vancomycin aglycon, and related key compounds: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding.
    Xie J; Okano A; Pierce JG; James RC; Stamm S; Crane CM; Boger DL
    J Am Chem Soc; 2012 Jan; 134(2):1284-97. PubMed ID: 22188323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Killing Mechanism of Teixobactin against Methicillin-Resistant Staphylococcus aureus: an Untargeted Metabolomics Study.
    Hussein M; Karas JA; Schneider-Futschik EK; Chen F; Swarbrick J; Paulin OKA; Hoyer D; Baker M; Zhu Y; Li J; Velkov T
    mSystems; 2020 May; 5(3):. PubMed ID: 32457238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural variations of the cell wall precursor lipid II and their influence on binding and activity of the lipoglycopeptide antibiotic oritavancin.
    Münch D; Engels I; Müller A; Reder-Christ K; Falkenstein-Paul H; Bierbaum G; Grein F; Bendas G; Sahl HG; Schneider T
    Antimicrob Agents Chemother; 2015 Feb; 59(2):772-81. PubMed ID: 25403671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin-Resistant Staphylococcus aureus - Delaware, 2015.
    Walters MS; Eggers P; Albrecht V; Travis T; Lonsway D; Hovan G; Taylor D; Rasheed K; Limbago B; Kallen A
    MMWR Morb Mortal Wkly Rep; 2015 Sep; 64(37):1056. PubMed ID: 26402026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorobiphenyl-desleucyl-vancomycin inhibits the transglycosylation process required for peptidoglycan synthesis in bacteria in the absence of dipeptide binding.
    Goldman RC; Baizman ER; Longley CB; Branstrom AA
    FEMS Microbiol Lett; 2000 Feb; 183(2):209-14. PubMed ID: 10675585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin analogs: Seeking improved binding of d-Ala-d-Ala and d-Ala-d-Lac peptides by side-chain and backbone modifications.
    Leung SS; Tirado-Rives J; Jorgensen WL
    Bioorg Med Chem; 2009 Aug; 17(16):5874-86. PubMed ID: 19620008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hidden Mode of Action of Glycopeptide Antibiotics: Inhibition of Wall Teichoic Acid Biosynthesis.
    Singh M; Chang J; Coffman L; Kim SJ
    J Phys Chem B; 2017 Apr; 121(16):3925-3932. PubMed ID: 28368603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.